TY - JOUR
T1 - Effects of bisphenol A on the reproduction of Japanese medaka (Oryzias latipes)
AU - Kang, Ik Joon
AU - Yokota, Hirofumi
AU - Oshima, Yuji
AU - Tsuruda, Yukinari
AU - Oe, Toshiaki
AU - Imada, Nobuyoshi
AU - Tadokoro, Hiroshi
AU - Honjo, Tsuneo
PY - 2002/11/1
Y1 - 2002/11/1
N2 - We elucidated the effects of bisphenol A (BPA) on the reproductive capacity (fecundity and fertility) and estrogenic response of adult Japanese medaka (Oryzias latipes) and studied the transgenerational effects (F1 generation growth and sex) of this agent on the F1 offspring. Eight mating pairs of medaka were exposed to BPA for three weeks at a measured concentration of 837, 1,720, or 3,120 μg/L. Throughout the exposure period, we observed no reduction of fecundity and fertility in any treatment group and no reduction in survival and growth or any imbalance of the sex ratio of the offspring. However, histologic examination revealed testis-ova in 13% of the males in the 837-μg/L treatment group, 86% of those in the 1,720-μg/L group, and 50% of those that received 3,120 μg BPA/L. In addition, concentrations of hepatic vitellogenin were increased significantly in males treated with BPA at 3,120 μg/L (p = 0.0148). These results suggest that BPA is a weakly estrogenic compound that has the potential to alter sexual development and induce vitellogenin in male medaka but that has no adverse effect on reproductive success.
AB - We elucidated the effects of bisphenol A (BPA) on the reproductive capacity (fecundity and fertility) and estrogenic response of adult Japanese medaka (Oryzias latipes) and studied the transgenerational effects (F1 generation growth and sex) of this agent on the F1 offspring. Eight mating pairs of medaka were exposed to BPA for three weeks at a measured concentration of 837, 1,720, or 3,120 μg/L. Throughout the exposure period, we observed no reduction of fecundity and fertility in any treatment group and no reduction in survival and growth or any imbalance of the sex ratio of the offspring. However, histologic examination revealed testis-ova in 13% of the males in the 837-μg/L treatment group, 86% of those in the 1,720-μg/L group, and 50% of those that received 3,120 μg BPA/L. In addition, concentrations of hepatic vitellogenin were increased significantly in males treated with BPA at 3,120 μg/L (p = 0.0148). These results suggest that BPA is a weakly estrogenic compound that has the potential to alter sexual development and induce vitellogenin in male medaka but that has no adverse effect on reproductive success.
UR - http://www.scopus.com/inward/record.url?scp=0036837680&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036837680&partnerID=8YFLogxK
U2 - 10.1002/etc.5620211119
DO - 10.1002/etc.5620211119
M3 - Article
C2 - 12389919
AN - SCOPUS:0036837680
SN - 0730-7268
VL - 21
SP - 2394
EP - 2400
JO - Environmental Toxicology and Chemistry
JF - Environmental Toxicology and Chemistry
IS - 11
ER -